Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer.

Laklai H, Laval S, Dumartin L, Rochaix P, Hagedorn M, Bikfalvi A, Le Guellec S, Delisle MB, Schally AV, Susini C, Pyronnet S, Bousquet C.

Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17769-74. doi: 10.1073/pnas.0908674106. Epub 2009 Oct 1.

2.

Regulation of tumor angiogenesis by thrombospondin-1.

Ren B, Yee KO, Lawler J, Khosravi-Far R.

Biochim Biophys Acta. 2006 Apr;1765(2):178-88. Epub 2005 Dec 21. Review.

PMID:
16406676
3.

Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.

Rusnati M, Urbinati C, Bonifacio S, Presta M, Taraboletti G.

Pharmaceuticals (Basel). 2010 Apr 23;3(4):1241-1278. Review.

4.

Thrombospondin-1: multiple paths to inflammation.

Lopez-Dee Z, Pidcock K, Gutierrez LS.

Mediators Inflamm. 2011;2011:296069. doi: 10.1155/2011/296069. Epub 2011 Jul 3. Review.

Supplemental Content

Support Center